As of the latest Form 4 filed Jul 9, 2026.
What Abeona Therapeutics Inc insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 23 most recent filings for ABEO.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-07-09 | 2026-07-09 | Vazzano Joseph Walter Chief Financial Officer | SSale | −24.9K | $6.96 | $173K | No | Form 4 ↗ |
| 2026-07-09 | 2026-07-09 | Seshadri Vishwas Chief Executive Officer | SSale | −68.0K | $6.96 | $473K | No | Form 4 ↗ |
| 2026-07-09 | 2026-07-09 | O'Malley Brendan M. SVP, Chief Legal Officer | SSale | −12.1K | $6.96 | $83.9K | No | Form 4 ↗ |
| 2026-07-09 | 2026-07-09 | Vasanthavada Madhav Chief Commercial Officer | SSale | −12.6K | $6.96 | $87.8K | No | Form 4 ↗ |
| 2026-07-02 | 2026-06-30 | Alland Leila Director | SSale | −11.0K | $5.92 | $65.1K | No | Form 4 ↗ |
| 2026-06-17 | 2026-06-16 | Vasanthavada Madhav Chief Commercial Officer | JOther | −222.00 | $5.67 | $1.26K | No | Form 4 ↗ |
| 2026-06-15 | 2026-06-15 | Silverstein Christine Berni Director | SSale | −18.2K | $5.71 | $104K | No | Form 4 ↗ |
| 2026-06-09 | 2026-06-09 | Vazzano Joseph Walter Chief Financial Officer | SSale | −25.6K | $5.39 | $138K | Yes (planned) | Form 4 ↗ |
| 2026-06-09 | 2026-06-09 | Vazzano Joseph Walter, Chief Financial Officer | SSale | −13.4K | $5.30 | $71.2K | Yes (planned) | Form 4 ↗ |
| 2026-06-09 | 2026-06-09 | Vasanthavada Madhav Chief Commercial Officer | SSale | −5.45K | $5.30 | $28.9K | No | Form 4 ↗ |
| 2026-06-09 | 2026-06-09 | Seshadri Vishwas Chief Executive Officer | SSale | −31.9K | $5.30 | $169K | No | Form 4 ↗ |
| 2026-06-09 | 2026-06-09 | O'Malley Brendan M. SVP, Chief Legal Officer | SSale | −6.30K | $5.30 | $33.4K | No | Form 4 ↗ |
| 2026-06-09 | 2026-06-08 | Vazzano Joseph Walter Chief Financial Officer | SSale | −10.3K | $5.43 | $55.8K | Yes (planned) | Form 4 ↗ |
| 2026-06-09 | 2026-06-08 | Vasanthavada Madhav Chief Commercial Officer | SSale | −4.17K | $5.43 | $22.6K | No | Form 4 ↗ |
| 2026-06-09 | 2026-06-08 | Seshadri Vishwas Chief Executive Officer | SSale | −24.4K | $5.43 | $133K | No | Form 4 ↗ |
| 2026-06-09 | 2026-06-08 | O'Malley Brendan M. SVP, Chief Legal Officer | SSale | −4.83K | $5.43 | $26.2K | No | Form 4 ↗ |
| 2026-05-26 | 2026-05-26 | Alvino Mark Director | GGift | −500.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-22 | 2026-05-22 | Alvino Mark Director | SSale | −6.50K | $5.46 | $35.5K | No | Form 4 ↗ |
| 2026-05-15 | 2026-05-15 | Crombez Eric Director | SSale | −26.1K | $5.53 | $145K | Yes (planned) | Form 4 ↗ |
| 2026-05-11 | 2026-05-11 | Vasanthavada Madhav Chief Commercial Officer | SSale | −5.55K | $5.96 | $33.1K | No | Form 4 ↗ |
| 2026-04-07 | 2026-04-01 | Goldan Keith A. Director | AAward | +32.8K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-31 | 2026-03-31 | Seshadri Vishwas Chief Executive Officer | SSale | −30.0K | $4.38 | $131K | Yes (planned) | Form 4 ↗ |
| 2026-03-16 | 2026-03-16 | Vazzano Joseph Walter Chief Financial Officer | SSale | −785.00 | $4.76 | $3.74K | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also ABEO’s full analysis or the market-wide insider trading feed. The tabs above jump to ABEO’s other SEC data.
Source: SEC Form 4 filings for ABEO, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.